Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fortitech is a global leader in the development and manufacture of custom nutrient premixes for the food, beverage, and pharmaceutical industries. The company specializes in the precise integration of vitamins, minerals, amino acids, nucleotides, and botanicals into functional products. Their expertise covers a wide range of applications, including infant formula, dietary supplements, and medical foods. In 2012, Fortitech was acquired by DSM for $634 million, enhancing DSM's capabilities in human nutrition and health. The company continues to provide tailored formulation and manufacturing services as part of the dsm-firmenich group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fortitech.